HIF1A and breast carcinoma: We generated MCF-7 breast cancer cells stably expressing HIF-1α (MCF-7/HIF-1α), which were resistant to endocrine therapy and found that targeting HIF-1α reversed endocrine resistance both in vitro and in vivo.